In the preceding three months, 19 analysts have released ratings for Axsome Therapeutics (NASDAQ:AXSM), presenting a wide array of perspectives from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 9 | 9 | 1 | 0 | 0 |
Last 30D | 0 | 1 | 0 | 0 | 0 |
1M Ago | 2 | 4 | 0 | 0 | 0 |
2M Ago | 6 | 2 | 0 | 0 | 0 |
3M Ago | 1 | 2 | 1 | 0 | 0 |
The 12-month price targets, analyzed by analysts, offer insights with an average target of $128.05, a high estimate of $180.00, and a low estimate of $95.00. This current average has increased by 0.5% from the previous average price target of $127.41.
Investigating Analyst Ratings: An Elaborate Study
The standing of Axsome Therapeutics among financial experts becomes...
Login or create a forever free account to read this news
Sign up/Log in